Cooper Financial Group Amgen Inc Transaction History

Cooper Financial Group

$752 Million
Q3 2024

A detailed history of Cooper Financial Group transactions in Amgen Inc stock. As of the latest transaction made, Cooper Financial Group holds 7,902 shares of AMGN stock, worth $2.21 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

7,902

Previous 7,686 2.81%

Holding current value

$2.21 Million

Previous $2.4 Million 6.04%

% of portfolio

0.34%

Previous 0.36%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $66,826 - $72,874	216 Added 2.81%	7,902 $2.55 Million
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $192,333 - $233,734	-732 Reduced 8.7%	7,686 $2.4 Million
Q1 2024 Apr 11, 2024	SELL	$268.87 - $324.56 $16,132 - $19,473	-60 Reduced 0.71%	8,418 $2.39 Million
Q4 2023 Jan 16, 2024	BUY	$255.7 - $288.46 $125,293 - $141,345	490 Added 6.13%	8,478 $2.44 Million
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $14,868 - $18,459	-68 Reduced 0.84%	7,988 $2.15 Million
Q2 2023 Jul 07, 2023	SELL	$214.27 - $253.37 $24,212 - $28,630	-113 Reduced 1.38%	8,056 $1.79 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $81,735 - $99,622	362 Added 4.64%	8,169 $1.97 Million
Q4 2022 Jan 13, 2023	BUY	$229.03 - $291.01 $8,474 - $10,767	37 Added 0.48%	7,807 $0
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $31,199 - $35,187	139 Added 1.82%	7,770 $1.75 Million
Q2 2022 Jul 11, 2022	SELL	$230.71 - $256.74 $31,376 - $34,916	-136 Reduced 1.75%	7,631 $1.86 Million
Q1 2022 Apr 12, 2022	BUY	$219.27 - $242.57 $39,468 - $43,662	180 Added 2.37%	7,767 $1.88 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $152,938 - $175,024	-769 Reduced 9.2%	7,587 $1.71 Million
Q3 2021 Oct 06, 2021	BUY	$212.27 - $248.7 $42,878 - $50,237	202 Added 2.48%	8,356 $1.78 Million
Q2 2021 Jul 12, 2021	BUY	$233.58 - $259.14 $62,132 - $68,931	266 Added 3.37%	8,154 $1.99 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $233,449 - $272,047	-1,052 Reduced 11.77%	7,888 $1.96 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $270,475 - $322,087	1,250 Added 16.25%	8,940 $2.06 Million
Q3 2020 Oct 09, 2020	SELL	$234.65 - $260.95 $70,629 - $78,545	-301 Reduced 3.77%	7,690 $1.95 Million
Q2 2020 Jul 15, 2020	BUY	$197.81 - $242.74 $471,381 - $578,449	2,383 Added 42.49%	7,991 $1.89 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $82,554 - $109,490	453 Added 8.79%	5,608 $1.14 Million
Q4 2019 Jan 07, 2020	SELL	$189.21 - $243.2 $17,407 - $22,374	-92 Reduced 1.75%	5,155 $1.24 Million
Q3 2019 Oct 08, 2019	BUY	$174.11 - $208.62 $174,632 - $209,245	1,003 Added 23.63%	5,247 $1.02 Million
Q2 2019 Jul 08, 2019	BUY	$166.7 - $195.41 $154,197 - $180,754	925 Added 27.87%	4,244 $782,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $136,918 - $154,337	-757 Reduced 18.57%	3,319 $631,000
Q4 2018 Jan 17, 2019	BUY	$178.4 - $208.25 $727,158 - $848,827	4,076 New	4,076 $794,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.

Account

Cooper Financial Group Amgen Inc Transaction History